Daniel Addison
Director, Translational Research · University of Texas Southwestern Medical Center
Credentials: · · · · ·
History
- 2017–2018
National Cancer Institute Alliance
- 2016–2017
2005–2009
Research
Hypertension and incident cardiovascular events following ibrutinib initiation
Blood · 2019 · Last of 13 authors · 219 citations
Journal of the American College of Cardiology · 2017 · 157 citations
European Heart Journal · 2022 · Last of 7 authors · 118 citations
47 papers · 1 as a fellow
17 papers
14 papers
14 papers
- AD
13 papers · 10 as a resident
12 papers
- OK
11 papers · 1 as a resident
10 papers · 1 as a resident
Grants
- 2025–2030
National Cancer Institute · R01
PI · $1.3M · Ohio State University
- 2023–2028
Novel Patient Biomarkers and Mechanisms of TKI Associated Cardiotoxicity
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.7M · Ut Southwestern Medical Center
- 2024–2027
Therapeutic Strategies to Mitigate Toxicities of Anthracycline-Based Therapeutics
National Heart, Lung, and Blood Institute · R01
PI · $2.2M · Ohio State University
- 2021–2026
Early Detection and Mechanisms of Cancer Immunotherapy Associated Cardiotoxicity
National Heart, Lung, and Blood Institute · K23
Contact PI · $662.7K · Ohio State University